drugset / Trial / NCT06813118

Comparison of Clomid and Lezra With Lezra for Ovulation Induction in Clomid Resistant PCOS Case

NCT06813118

Phase 1 Completed 42 enrolled HITEC-Institute of Medical Sciences
RandomizedParallel-groupSingle-blindTreatment

Summary

Clomiphene citrate resistant i.e failure to ovulate after 6 cycles of ovulation induction effects 15-40% of patients with PCOS.Two treatment groups will be formed one recieving letrozole alone and another recieving CC and letrozole combined.Mature follicles and endometrial thickness will be checked by transvaginal ultrasound and results will be recorded.

Timeline

Start
2024-06-07
Primary completion
2025-03-25
Completion
2025-03-25

Drugs

EvaluationDrugModalityDoseRoute
Subject Clomiphene Other / unclassified 100 mg
Subject Letrozole Other / unclassified 5 mg